Mirae Asset Global Investments Co. Ltd. Acquires Shares of 22,487 Revvity, Inc. (NYSE:RVTY)

Mirae Asset Global Investments Co. Ltd. purchased a new stake in Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 22,487 shares of the company's stock, valued at approximately $2,458,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Gladius Capital Management LP boosted its holdings in shares of Revvity by 84.1% in the third quarter. Gladius Capital Management LP now owns 232 shares of the company's stock valued at $26,000 after acquiring an additional 106 shares during the period. CENTRAL TRUST Co acquired a new stake in shares of Revvity in the fourth quarter valued at approximately $27,000. JTC Employer Solutions Trustee Ltd acquired a new stake in shares of Revvity in the fourth quarter valued at approximately $33,000. Headinvest LLC acquired a new stake in shares of Revvity in the third quarter valued at approximately $57,000. Finally, DB Wealth Management Group LLC acquired a new stake in shares of Revvity in the fourth quarter valued at approximately $79,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently weighed in on RVTY. UBS Group downgraded Revvity from a "buy" rating to a "neutral" rating and increased their price target for the stock from $105.00 to $125.00 in a report on Tuesday, January 16th. Raymond James increased their price target on Revvity from $106.00 to $127.00 and gave the stock an "outperform" rating in a report on Friday, February 2nd. Stifel Nicolaus increased their price target on Revvity from $95.00 to $110.00 and gave the stock a "hold" rating in a report on Friday, February 2nd. Barclays increased their price objective on Revvity from $92.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Thursday, January 25th. Finally, Evercore ISI upgraded Revvity from an "in-line" rating to an "outperform" rating and increased their price objective for the stock from $88.00 to $125.00 in a research report on Thursday, January 4th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Revvity currently has a consensus rating of "Moderate Buy" and an average target price of $118.91.

Insider Buying and Selling at Revvity

In other news, insider Prahlad R. Singh sold 21,217 shares of the business's stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now owns 92,801 shares in the company, valued at approximately $9,677,288.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.60% of the stock is owned by company insiders.

Revvity Price Performance

RVTY stock traded up $1.48 during trading on Friday, hitting $100.86. The stock had a trading volume of 731,055 shares, compared to its average volume of 858,102. The company's 50 day moving average price is $104.83 and its two-hundred day moving average price is $101.69. Revvity, Inc. has a 1-year low of $79.50 and a 1-year high of $135.67. The stock has a market cap of $12.46 billion, a price-to-earnings ratio of 18.36, a price-to-earnings-growth ratio of 2.62 and a beta of 1.09. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.77 and a current ratio of 2.07.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.10. The firm had revenue of $695.90 million during the quarter. Revvity had a net margin of 25.20% and a return on equity of 7.41%. On average, sell-side analysts forecast that Revvity, Inc. will post 4.65 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, April 19th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend is Thursday, April 18th. Revvity's dividend payout ratio (DPR) is 5.09%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.